Byrd, J. C. Et Al. 2021. First results of a head-to-head trial of acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia.. JOURNAL OF CLINICAL ONCOLOGY , vol.39, no.15 .

Byrd, J. C., Hillmen, P., Ghia, P., Kater, A. P., Chanan-Khan, A. A. A., Furman, R. R., ... O'Brien, S. M.(2021). First results of a head-to-head trial of acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia.. JOURNAL OF CLINICAL ONCOLOGY , vol.39, no.15.

Byrd, John Et Al. "First results of a head-to-head trial of acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia.," JOURNAL OF CLINICAL ONCOLOGY , vol.39, no.15, 2021

Byrd, John C. Et Al. "First results of a head-to-head trial of acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia.." JOURNAL OF CLINICAL ONCOLOGY , vol.39, no.15, 2021

Byrd, J. C. Et Al. (2021) . "First results of a head-to-head trial of acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia.." JOURNAL OF CLINICAL ONCOLOGY , vol.39, no.15.

@article{article, author={John C. Byrd Et Al. }, title={First results of a head-to-head trial of acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia.}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2021}